Characterization of the modified Hodge test-positive isolates of Enterobacteriaceae in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 1, 2013, Pages 35-40

  Hung, Kuei Hsiang ^a   Yan, Jing Jou ^b   Lu, Jang Jih ^c   Chen, Hung Mo ^b   Wu, Jiunn Jong ^a,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

AmpC; Carbapenemase; ESBL; Modified Hodge test; Outer membrane protein

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE AMPC; BORONIC ACID DERIVATIVE; CARBAPENEMASE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; OUTER MEMBRANE PROTEIN; TIOXAPROFEN;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CITROBACTER FREUNDII; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENOTYPE; HODGE TEST; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; TAIWAN;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAMASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PROTEOME; TAIWAN;

EID: 84872604998     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.01.001     Document Type: Article

References (24)

1. Oteo J., Pérez-Vázquez M., Campos J. Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010, 23:320-326.
2. Nordmann P., Cuzon G., Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009, 9:228-236.
3. Carvalhaes C.G., Picão R.C., Nicoletti A.G., Xavier D.E., Gales A.C. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J Antimicrob Chemother 2010, 65:249-251.
4. Hoban D.J., Bouchillon S.K., Hawser S.P., Badal R.E. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the study for monitoring antimicrobial resistance trends 2002 to 2007. Diagn Microbiol Infect Dis 2010, 66:78-86.
5. Hsueh P.R., Badal R.E., Hawser S.P., Hoban D.J., Bouchillon S.K., Ni Y., et al. Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int J Antimicrob Agents 2010, 36:408-414.
6. Yan J.J., Wu J.J., Lee C.C., Ko W.C., Yang F.C. Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007. Eur J Clin Microbiol Infect Dis 2010, 29:1417-1425.
7. Stapleton P.D., Shannon K.P., French G.L. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 1999, 43:1206-1210.
8. Lartigue M.F., Poirel L., Poyart C., Réglier-Poupet H., Nordmann P. Ertapenem resistance of Escherichia coli. Emerg Infect Dis 2007, 13:315-317.
9. Liu Y.F., Yan J.J., Ko W.C., Tsai S.H., Wu J.J. Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan. J Antimicrob Chemother 2008, 61:1020-1023.
10. Hawkey P.M., Jones A.M. The changing epidemiology of resistance. J Antimicrob Chemother 2009, 64(Suppl. 1):i3-i10.
11. Cohen Stuart J., Leverstein-Van Hall M.A. Dutch Working Party on the Detection of Highly Resistant Microorganisms. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 2010, 36:205-210.
12. Performance standards for antimicrobial susceptibility testing. 21st informational supplement. M100-S21 2011, Clinical and Laboratory Standards Institute (CLSI), CLSI, Wayne, PA.
13. Pasteran F., Mendez T., Guerriero L., Rapoport M., Corso A. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol 2009, 47:1631-1639.
14. Pasteran F., Mendez T., Rapoport M., Guerriero L., Corso A. Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class A carbapenemase in species of Enterobacteriaceae by incorporating boronic acid. J Clin Microbiol 2010, 48:1323-1332.
15. Pournaras S., Poulou A., Tsakris A. Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds. J Antimicrob Chemother 2010, 65:1319-1321.
16. Endimiani A., Perez F., Bajaksouzian S., Windau A.R., Good C.E., Choudhary Y., et al. Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility. J Clin Microbiol 2010, 48:4417-4425.
17. Tsakris A., Themeli-Digalaki K., Poulou A., Vrioni G., Voulgari E., Koumaki V., et al. Comparative evaluation of boronic acid combined-disk tests for the detection of KPC carbapenemase-producing Enterobacteriaceae clinical isolates. J Clin Microbiol 2011, 49:2804-2809.
18. Song W., Jeong S.H., Kim J.S., Kim H.S., Shin D.H., Roh K.H., et al. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. Diagn Microbiol Infect Dis 2007, 57:315-318.
19. Yan J.J., Wu J.J., Tsai S.H., Chuang C.L. Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-beta-lactamases in gram-negative bacilli. Diagn Microbiol Infect Dis 2004, 49:5-11.
20. Antibiotics in laboratory medicine 1996, Williams & Wilkins Press, New York City. 4th ed. V. Lorian (Ed.).
21. Chung K.P., Tseng S.P., Huang Y.T., Tsai T.H., Teng L.J., Hsueh P.R. Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan. J Antimicrob Chemother 2011, 66:1182-1184.
22. Wu J.J., Wang L.R., Liu Y.F., Chen H.M., Yan J.J. Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital. Microb Drug Resist 2011, 17:259-266.
23. Mainardi J.L., Mugnier P., Coutrot A., Buu-Hoï A., Collatz E., Gutmann L. Carbapenem resistance in a clinical isolate of Citrobacter freundii. Antimicrob Agents Chemother 1997, 41:2352-2354.
24. Zhang R., Yang L., Cai J.C., Zhou H.W., Chen G.X. High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol 2008, 57:332-337.